{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:39:14Z","timestamp":1791513554025,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jconrel.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T23:46:52Z","timestamp":1399679212000},"page":"189-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":406,"special_numbering":"C","title":["Chitosan in nasal delivery systems for therapeutic drugs"],"prefix":"10.1016","volume":"190","author":[{"given":"Luca","family":"Casettari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Illum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.05.003_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","article-title":"Nasal drug delivery \u2014 recent developments and future prospects","volume":"161","author":"Illum","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4637.2007.00300.x","article-title":"Analgesic efficacy and safety of morphine\u2013chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery","volume":"9","author":"Stoker","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/138161213804143662","article-title":"Intranasal drug delivery to the central nervous system: present status and future outlook","volume":"19","author":"Tayebati","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/jcbfm.2013.41","article-title":"Accessing the brain: the nose may know the way","volume":"33","author":"Djupesland","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0035","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Ilium","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery \u2014 possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10611869808997870","article-title":"Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?","volume":"5","author":"Mathison","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0055","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.1998.274.1.F1","article-title":"Molecular structure and assembly of the tight junction","volume":"274","author":"Denker","year":"1998","journal-title":"Am. J. Physiol. Renal. Physiol"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1461-5347(99)00170-4","article-title":"Regulation of the intestinal epithelial paracellular barrier","volume":"2","author":"Daugherty","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0065","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1529\/biophysj.107.107888","article-title":"Insulin transport within skeletal muscle transverse tubule networks","volume":"93","author":"Shorten","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2174\/1381612043384826","article-title":"New technologies for drug delivery across the blood brain barrier","volume":"10","author":"Kabanov","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0075","doi-asserted-by":"crossref","first-page":"16424","DOI":"10.1021\/bi991765q","article-title":"Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques","volume":"38","author":"Wilkins","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1018911206646","article-title":"Drug metabolism in the nasal mucosa","volume":"9","author":"Sarkar","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0085","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.902940212","article-title":"Ultrastructure of substance P- and CGRP-immunoreactive nerve fibers in the nasal epithelium of rodents","volume":"294","author":"Finger","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cne.10143","article-title":"Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli","volume":"444","author":"Schaefer","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0100","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Illum","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0630","series-title":"Biological and Pharmacological Activity of Chitosan and Derivatives","first-page":"75","author":"Cunha","year":"2012"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yrtph.2009.09.015","article-title":"The safety of chitosan as a pharmaceutical excipient","volume":"56","author":"Baldrick","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0125","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.biomaterials.2004.06.020","article-title":"Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption","volume":"26","author":"Smith","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0130","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/bm100522c","article-title":"Effect of PEGylation on the toxicity and permeability enhancement of chitosan","volume":"11","author":"Casettari","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.progpolymsci.2011.10.001","article-title":"PEGylated chitosan derivatives: synthesis, characterizations and pharmaceutical applications","volume":"37","author":"Casettari","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2013.10.022","article-title":"Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: from synthesis to in vitro application","volume":"173","author":"Benediktsd\u00f3ttir","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1018901302450","article-title":"Chitosan as a novel nasal delivery system for peptide drugs","volume":"11","author":"Illum","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0142-9612(00)00231-3","article-title":"Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches","volume":"22","author":"Van Der Lubben","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10717540500309040","article-title":"Nasal delivery of insulin using bioadhesive chitosan gels","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0160","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.biomaterials.2006.12.024","article-title":"A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system","volume":"28","author":"Wu","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/187221109787158346","article-title":"Chitosan and its use in design of insulin delivery system","volume":"3","author":"Wong","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/10717541003762888","article-title":"Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride","volume":"17","author":"du Plessis","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejpb.2010.04.013","article-title":"Freeze-dried chitosan\/pectin nasal inserts for antipsychotic drug delivery","volume":"75","author":"Luppi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0180","first-page":"765","article-title":"Recent advances of chitosan nanoparticles as drug carriers","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.colsurfb.2011.01.030","article-title":"Chitosan microspheres as a delivery system for nasal insufflation","volume":"84","author":"Patil","year":"2011","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejps.2006.11.018","article-title":"Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device","volume":"30","author":"Charlton","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2006.12.014","article-title":"Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies","volume":"118","author":"Charlton","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejpb.2008.07.005","article-title":"Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting","volume":"70","author":"Wang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0205","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/jps.21674","article-title":"Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake","volume":"98","author":"Vaka","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carbpol.2013.08.027","article-title":"Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats","volume":"99","author":"Bshara","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0635","series-title":"Blood Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects","article-title":"Intranasal delivery to the CNS","author":"Illum","year":"2014"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0225","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1023\/A:1025722614154","article-title":"The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model","volume":"20","author":"Illum","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0230","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00602-0","article-title":"Clearance characteristics of chitosan based formulations in the sheep nasal cavity","volume":"217","author":"Soane","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0240","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fern\u00e1ndez-Urrusuno","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0245","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s11095-005-8175-y","article-title":"Uptake and transport of PEG-graft\u2013trimethyl-chitosan copolymer\u2013insulin nanocomplexes by epithelial cells","volume":"22","author":"Mao","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.05.007","article-title":"Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies","volume":"281","author":"Yu","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0640","first-page":"89","article-title":"Novel chitosan-based delivery systems for the nasal administration of a LHRH-analogue","volume":"10","author":"Illum","year":"2000","journal-title":"STP Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.1999.00894.x","article-title":"Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks","volume":"47","author":"Roon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0270","series-title":"Polysaccharides","first-page":"643","article-title":"Chitosan as a delivery system for the transmucosal administration of drugs","author":"Illum","year":"2005"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2005.09.013","article-title":"Nasal administration of carbamazepine using chitosan microspheres: in vitro\/in vivo studies","volume":"307","author":"Gavini","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/10611861003663523","article-title":"Mucoadhesive chitosan microspheres of carvedilol for nasal administration","volume":"18","author":"Patil","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0285","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jps.22314","article-title":"Poloxamer\/cyclodextrin\/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride","volume":"100","author":"Cho","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0290","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbm.b.31161","article-title":"Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin","volume":"88B","author":"Wang","year":"2009","journal-title":"J. Biomed. Mater. Res. B"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0300","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2007.08.009","article-title":"Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles","volume":"68","author":"Zhang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0305","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.carbpol.2010.04.068","article-title":"Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: in vitro characterization and in vivo study","volume":"82","author":"Chung","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0315","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bm9001377","article-title":"Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules","volume":"10","author":"Goycoolea","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijpharm.2005.10.016","article-title":"Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery","volume":"307","author":"Krauland","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0325","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/C2BM00132B","article-title":"A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation","volume":"1","author":"Nazar","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0330","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02652040400015403","article-title":"Nasal delivery of insulin using chitosan microspheres","volume":"21","author":"Varshosaz","year":"2004","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2010.06.048","article-title":"Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats","volume":"397","author":"Na","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2012.10.030","article-title":"A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats","volume":"48","author":"Na","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0345","first-page":"249","article-title":"Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac","volume":"66","author":"Nagda","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0350","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2012.02.044","article-title":"Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization","volume":"428","author":"Shahnaz","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2011.06.009","article-title":"Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery","volume":"416","author":"Cho","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/03639040802395185","article-title":"The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration","volume":"35","author":"Sun","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0365","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2006.07.040","article-title":"Rapid-onset intranasal delivery of metoclopramide hydrochloride: part I. Influence of formulation variables on drug absorption in anesthetized rats","volume":"327","author":"Zaki","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejpb.2007.05.002","article-title":"Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide","volume":"68","author":"Gavini","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0375","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.301.1.391","article-title":"Intranasal delivery of morphine","volume":"301","author":"Illum","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0380","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0885-3924(02)00522-5","article-title":"Pilot study of nasal morphine\u2013chitosan for the relief of breakthrough pain in patients with cancer","volume":"24","author":"Pavis","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4637.2007.00300.x","article-title":"Analgesic efficacy and safety of morphine\u2013chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery","volume":"9","author":"Stoker","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0390","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/03639040903517906","article-title":"Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes","volume":"36","author":"Gungor","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0395","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18433\/J3CS3F","article-title":"Nasal delivery of recombinant human growth hormone: in vivo evaluation with Pheroid\u2122 technology and N-trimethyl chitosan chloride","volume":"13","author":"Steyn","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejps.2005.03.014","article-title":"Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations","volume":"26","author":"Cheng","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0405","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3797\/scipharm.1208-18","article-title":"Intranasal delivery of chitosan nanoparticles for migraine therapy","volume":"81","author":"Gulati","year":"2013","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0410","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ejpb.2008.06.031","article-title":"Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats","volume":"70","author":"Mei","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0415","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.peptides.2005.09.008","article-title":"Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague\u2013Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers","volume":"27","author":"Wang","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejps.2013.08.029","article-title":"Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres","volume":"51","author":"Mouez","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0425","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejps.2009.07.003","article-title":"Preparation of zolmitriptan\u2013chitosan microparticles by spray drying for nasal delivery","volume":"38","author":"Alhalaweh","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0430","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/03639045.2010.513009","article-title":"Bioavailability of \u03949-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits","volume":"37","author":"Al-Ghananeem","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0435","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I","article-title":"Nasal administration of morphine-6-glucuronide in sheep \u2014 a pharmacokinetic study","volume":"17","author":"Illum","year":"1996","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0440","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0445","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0141-8130(86)90007-3","article-title":"New method for the quaternization of chitosan","volume":"8","author":"Domard","year":"1986","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0450","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0939-6411(99)00006-5","article-title":"Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)","volume":"47","author":"Kotze","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0455","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2005.11.014","article-title":"Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system","volume":"111","author":"Amidi","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0460","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jps.21887","article-title":"Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides","volume":"99","author":"Vetter","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0465","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10611860903450031","article-title":"Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer\/glutathione microparticulate delivery system","volume":"18","author":"Vetter","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0470","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3109\/03639045.2011.584537","article-title":"Safety assessment of thiolated polymers: effect on ciliary beat frequency in human nasal epithelial cells","volume":"37","author":"Palmberger","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0475","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2012.10.030","article-title":"A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats","volume":"48","author":"Na","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0480","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ejpb.2008.06.031","article-title":"Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats","volume":"70","author":"Mei","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0490","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2005.11.014","article-title":"Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system","volume":"111","author":"Amidi","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0500","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/bm800975j","article-title":"New generation of hybrid poly\/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules","volume":"10","author":"Teijeiro-Osorio","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood\u2013brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0645","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.1999.00894.x","article-title":"Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks","volume":"47","author":"Roon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0515","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model","volume":"48","author":"Md","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0520","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3109\/03639045.2011.571696","article-title":"Delivery of cefotaxime to the brain via intranasal administration","volume":"37","author":"Manda","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0525","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/1061186X.2013.818676","article-title":"Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief","volume":"21","author":"Patel","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0530","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.colsurfb.2013.09.030","article-title":"Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment","volume":"113","author":"Sood","year":"2014","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0535","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10611860903483396","article-title":"Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses","volume":"18","author":"Al-Ghananeem","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0540","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijbiomac.2013.06.041","article-title":"Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery","volume":"61","author":"Kumar","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0545","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejpb.2013.06.005","article-title":"Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes","volume":"85","author":"Popov","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0550","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2012.10.049","article-title":"Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting","volume":"441","author":"Jose","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0555","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1002\/jps.21335","article-title":"Brain uptake of an anti-ischemic agent by nasal administration of microparticles","volume":"97","author":"Dalpiaz","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0560","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/10611860802476504","article-title":"Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting","volume":"16","author":"Kumar","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0565","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0570","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0575","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijbiomac.2013.04.024","article-title":"Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety","volume":"59","author":"Nagpal","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0580","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/jps.22382","article-title":"Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres","volume":"100","author":"Gavini","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0585","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1002\/jps.21751","article-title":"New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration","volume":"98","author":"Rassu","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0590","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0595","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jps.22780","article-title":"Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain","volume":"101","author":"Patel","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0600","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.carbpol.2012.02.051","article-title":"Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation","volume":"89","author":"Haque","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0605","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/156720112803529792","article-title":"Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation","volume":"9","author":"Bahudar","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0610","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2012.10.010","article-title":"Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting","volume":"83","author":"Gavini","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0615","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2012.10.049","article-title":"Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting","volume":"441","author":"Jose","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.05.003_bb0650","series-title":"Nanoparticles: Drug Inhalation Therapy","article-title":"The potential of nanoparticles for nose-to-brain delivery of drugs","author":"Illum","year":"2014"},{"key":"10.1016\/j.jconrel.2014.05.003_bb0625","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/08958370490439597","article-title":"Translocation of inhaled ultrafine particles to the brain","volume":"16","author":"Oberd\u00f6rster","year":"2004","journal-title":"Inhal. Toxicol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:41:39Z","timestamp":1572666099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":122,"alternative-id":["S0168365914002946"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.05.003","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan in nasal delivery systems for therapeutic drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}